首页> 外文OA文献 >Optimization of chemical reagent storage and distribution at Novartis Institutes for BioMedical Research
【2h】

Optimization of chemical reagent storage and distribution at Novartis Institutes for BioMedical Research

机译:诺华生物医学研究所化学试剂储存和分配的优化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Novartis Institutes for BioMedical Research is the drug discovery arm of Novartis Pharmaceuticals. Drug discovery is generally considered to be the primary driver for success in the pharmaceutical industry. Success in the early stages of drug discovery relies on dependable, innovative, disease related high-throughput screening of biological compounds and the creation of a screening deck of highly diverse, proprietary chemical compounds. In contrast with many of its peers, Novartis relies strongly on combinatorial chemistry to populate its screening deck. The Chemical Libraries (CLI) group is responsible for this approach at Novartis and delivers more than 100,000 compounds per year to the Novartis Compound Archive. Since the introduction of high-throughput screening and combinatorial chemistry techniques, the bottleneck in many drug discovery processes has shifted to the roles that support these high-volume techniques. The aim of this thesis is to provide a general collection of short and long-term suggestions for process improvement in the chemical supply process. This process includes compound search and ordering, order fulfillment, and compound delivery, was investigated.
机译:诺华生物医学研究所是诺华制药的药物研发部门。药物发现通常被认为是制药行业成功的主要动力。药物研发早期阶段的成功取决于对生物化合物的可靠,创新,与疾病相关的高通量筛选,以及建立高度多样化的专有化学化合物的筛选平台。与许多同行相比,诺华非常依赖组合化学来构成其筛选平台。化学图书馆(CLI)小组在诺华负责此方法,每年向诺华化合物档案馆提供100,000多种化合物。自从引入高通量筛选和组合化学技术以来,许多药物发现过程中的瓶颈已转变为支持这些高容量技术的角色。本文的目的是为化学品供应过程中的过程改进提供短期和长期建议的总体集合。研究了此过程,包括化合物搜索和订购,订单履行以及化合物交付。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号